Esther Martinborough
Director/Miembro de la Junta en CODEXIS, INC. .
Fortuna: 153 522 $ al 30/04/2024
Perfil
Esther Martinborough is an Independent Director at Codexis, Inc. since 2021.
She is also the Chief Scientific Officer at Escient Pharmaceuticals, Inc. since 2018.
Prior to her current positions, she worked as the Executive Director-Research at Receptos LLC from 2008 to 2018.
Dr. Martinborough holds a doctorate degree from the Swiss Federal Institute of Technology and a graduate degree from the University of California.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CODEXIS, INC.
0.08% | 18/04/2024 | 57 933 ( 0.08% ) | 153 522 $ | 30/04/2024 |
Cargos activos de Esther Martinborough
| Empresas | Cargo | Inicio |
|---|---|---|
| CODEXIS, INC. | Director/Miembro de la Junta | 02/02/2021 |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | 01/04/2023 |
Antiguos cargos conocidos de Esther Martinborough.
| Empresas | Cargo | Fin |
|---|---|---|
| RECEPTOS INC | Director/Miembro de la Junta | 01/01/2015 |
Formación de Esther Martinborough.
| Swiss Federal Institute of Technology | Doctorate Degree |
| University of California | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CODEXIS, INC. | Process Industries |
| Empresas privadas | 2 |
|---|---|
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Esther Martinborough